BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS
217 results:

  • 1. Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures.
    Fontana F; Sommariva M; Anselmi M; Bianchi F; Limonta P; Gagliano N
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247872
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs.
    Rangel MMM; Linhares LCM; de Oliveira KD; Suzuki DOH; Maglietti FH; de Nardi AB
    Sci Rep; 2023 Nov; 13(1):21078. PubMed ID: 38030630
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bloom syndrome patients and mice display accelerated epigenetic aging.
    Lee J; Zhang J; Flanagan M; Martinez JA; Cunniff C; Kucine N; Lu AT; Haghani A; Gordevičius J; Horvath S; Chang VY
    Aging Cell; 2023 Oct; 22(10):e13964. PubMed ID: 37594403
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast cancer: The GREENORBLUE Trial.
    Nguyen CL; Zhou M; Easwaralingam N; Seah JL; Azimi F; Mak C; Pulitano C; Warrier S
    Ann Surg Oncol; 2023 Oct; 30(11):6520-6527. PubMed ID: 37402976
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.
    Kobeissi I; Eljilany I; Achkar T; LaFramboise WA; Santana-Santos L; Tarhini AA
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175874
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis.
    Yarza R; Bover M; Herrera-Juarez M; Rey-Cardenas M; Paz-Ares L; Lopez-Martin JA; Haanen J
    Oncologist; 2023 Jun; 28(6):e406-e415. PubMed ID: 37036865
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ultrahypofractionated Low-Dose Total skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Elsayad K; Weishaupt C; Moustakis C; Danzer MF; Müller EC; Rolf D; Stranzenbach R; Livingstone E; Booken N; Stadler R; Eich HT
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):164-170. PubMed ID: 36893819
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.
    Liu HL; Chen YH; Chung CH; Wu GJ; Tsao CH; Sun CA; Chien WC; Hung CT
    Balkan Med J; 2023 Mar; 40(2):131-138. PubMed ID: 36804217
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Treatment and outcome trends and predictors of overall survival of rectal melanoma: Analysis of the National cancer Database.
    Emile SH; Horesh N; Freund MR; Garoufalia Z; Gefen R; Silva-Alvarenga E; Wexner SD
    Eur J Surg Oncol; 2023 Jul; 49(7):1275-1282. PubMed ID: 36732208
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Electrochemotherapy of melanoma: What we know and what is unexplored?
    Choromańska A; Szwedowicz U
    Adv Clin Exp Med; 2023 Jan; 32(1):5-8. PubMed ID: 36637184
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
    Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; Hogan SL; Derebail VK
    Nephrol Dial Transplant; 2023 Aug; 38(9):2009-2018. PubMed ID: 36549661
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy.
    Cristofani R; Piccolella M; Montagnani Marelli M; Tedesco B; Poletti A; Moretti RM
    Cell Death Dis; 2022 Nov; 13(11):973. PubMed ID: 36400750
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial.
    Zetner D; Kamby C; Gülen S; Christophersen C; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
    J Pineal Res; 2023 Jan; 74(1):e12840. PubMed ID: 36385713
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis.
    Ostapenko E; Nixdorf L; Devyatko Y; Exner R; Wimmer K; Fitzal F
    Ann Surg Oncol; 2023 Jan; 30(1):126-136. PubMed ID: 36245049
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ezh2
    Zimmerman SM; Nixon SJ; Chen PY; Raj L; Smith SR; Paolini RL; Lin PN; Souroullas GP
    Oncogene; 2022 Nov; 41(46):4983-4993. PubMed ID: 36220978
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
    Basak EA; Vermeer NS; de Joode K; Hurkmans DP; Velthuis DEM; Oomen-de Hoop E; Schreurs MWJ; Bins S; Koolen SLW; Debets R; van der Veldt AAM; Aerts JGJV; Joosse A; Mathijssen RHJ
    Eur J Cancer; 2022 Oct; 174():113-120. PubMed ID: 35988409
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Two-team-approached free flap reconstruction for plantar malignant melanoma: An observational (STROBE-compliant) trial.
    Kim JH; Lee CR; Kwon HJ; Oh DY; Jun YJ; Rhie JW; Moon SH
    Medicine (Baltimore); 2022 Jul; 101(30):e29442. PubMed ID: 35905277
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FSPBO-DQN: SeGAN based segmentation and Fractional Student Psychology Optimization enabled Deep Q Network for skin cancer detection in IoT applications.
    Kumar KS; Suganthi N; Muppidi S; Kumar BS
    Artif Intell Med; 2022 Jul; 129():102299. PubMed ID: 35659386
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
    Nikolaev S; Yurchenko AA; Sarasin A
    Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.